Morgan Stanley Abbott Laboratories Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Abbott Laboratories stock. As of the latest transaction made, Morgan Stanley holds 34,513,415 shares of ABT stock, worth $3.95 Billion. This represents 0.29% of its overall portfolio holdings.

Number of Shares

34,513,415

Previous 35,616,923 3.1%

Holding current value

$3.95 Billion

Previous $3.7 Billion 6.32%

% of portfolio

0.29%

Previous 0.29%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $110 Million - $130 Million	-1,103,508 Reduced 3.1%	34,513,415 $3.93 Billion
Q2 2024 Oct 17, 2024	SELL	$100.73 - $112.44 $39.8 Million - $44.4 Million	-395,059 Reduced 1.1%	35,616,923 $3.7 Billion
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $39.8 Million - $44.4 Million	-395,059 Reduced 1.1%	35,616,923 $3.7 Billion
Q1 2024 Oct 17, 2024	BUY	$109.52 - $120.96 $43.3 Million - $47.8 Million	395,059 Added 1.11%	36,011,982 $4.09 Billion
Q1 2024 Aug 16, 2024	BUY	$109.52 - $120.96 $8.23 Million - $9.09 Million	75,155 Added 0.21%	36,011,982 $4.09 Billion
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $8.23 Million - $9.09 Million	75,155 Added 0.21%	36,011,982 $4.09 Billion
Q4 2023 Aug 16, 2024	BUY	$90.19 - $110.4 $28.9 Million - $35.3 Million	319,904 Added 0.9%	35,936,827 $3.96 Billion
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $26.7 Million - $32.7 Million	296,425 Added 0.83%	35,936,827 $3.96 Billion
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $71 Million - $85.1 Million	-742,792 Reduced 2.04%	35,640,402 $3.45 Billion
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $29.1 Million - $32.4 Million	-288,539 Reduced 0.79%	36,383,194 $3.97 Billion
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $222 Million - $262 Million	-2,294,766 Reduced 5.89%	36,671,733 $3.71 Billion
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $465 Million - $545 Million	4,886,954 Added 14.34%	38,966,499 $4.28 Billion
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $229 Million - $265 Million	-2,364,827 Reduced 6.49%	34,079,545 $3.3 Billion
Q2 2022 Oct 27, 2022	BUY	$102.07 - $123.37 $670 Million - $809 Million	6,560,294 Added 21.95%	36,444,372 $3.96 Billion
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $670 Million - $809 Million	6,560,294 Added 21.95%	36,444,372 $3.96 Billion
Q1 2022 Oct 27, 2022	SELL	$114.02 - $139.04 $748 Million - $912 Million	-6,560,294 Reduced 18.0%	29,884,078 $3.54 Billion
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $64 Million - $78.1 Million	561,582 Added 1.92%	29,884,078 $3.54 Billion
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $104 Million - $128 Million	902,174 Added 3.17%	29,322,496 $4.13 Billion
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $3.32 Billion - $3.67 Billion	28,420,322 New	28,420,322 $3.36 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account